M C Raviglione

Summary

Affiliation: World Health Organization
Country: Switzerland

Publications

  1. ncbi The TB epidemic from 1992 to 2002
    Mario C Raviglione
    Tuberculosis Strategy and Operations, Stop TB Department, World Health Organization, 20 Avenue Appia, CH 1211 Geneva 27, Switzerland
    Tuberculosis (Edinb) 83:4-14. 2003
  2. ncbi The burden of drug-resistant tuberculosis and mechanisms for its control
    M C Raviglione
    Communicable Diseases, Stop TB, World Health Organization, Geneva, Switzerland
    Ann N Y Acad Sci 953:88-97. 2001
  3. ncbi WHO's new Stop TB Strategy
    Mario C Raviglione
    Stop TB Department of WHO, 20 Avenue Appia, CH-1211, Geneva 27, Switzerland
    Lancet 367:952-5. 2006
  4. ncbi Standard short-course chemotherapy for drug-resistant tuberculosis: treatment outcomes in 6 countries
    M A Espinal
    World Health Organization, Communicable Diseases Programme, Ave Appia 20, 1211 Geneva 27, Switzerland
    JAMA 283:2537-45. 2000
  5. ncbi Assessment of worldwide tuberculosis control. WHO Global Surveillance and Monitoring Project
    M C Raviglione
    Global Tuberculosis Programme, World Health Organization, Geneva, Switzerland
    Lancet 350:624-9. 1997
  6. ncbi Planning to improve global health: the next decade of tuberculosis control
    Dermot Maher
    Stop TB Department, WHO, Geneva, Switzerland
    Bull World Health Organ 85:341-7. 2007
  7. ncbi Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project
    C Dye
    Communicable Diseases Prevention and Control, World Health Organization, Geneva, Switzerland
    JAMA 282:677-86. 1999
  8. ncbi Global trends in resistance to antituberculosis drugs. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance
    M A Espinal
    Communicable Diseases Cluster, World Health Organization, Geneva, Switzerland
    N Engl J Med 344:1294-303. 2001
  9. ncbi Towards universal access to HIV prevention, treatment, care, and support: the role of tuberculosis/HIV collaboration
    Alasdair Reid
    Stop TB Department, WHO, Geneva, Switzerland
    Lancet Infect Dis 6:483-95. 2006
  10. ncbi DOTS expansion: will we reach the 2005 targets?
    L J Véron
    World Health Organization, Stop TB Department, Geneva, Switzerland
    Int J Tuberc Lung Dis 8:139-46. 2004

Detail Information

Publications38

  1. ncbi The TB epidemic from 1992 to 2002
    Mario C Raviglione
    Tuberculosis Strategy and Operations, Stop TB Department, World Health Organization, 20 Avenue Appia, CH 1211 Geneva 27, Switzerland
    Tuberculosis (Edinb) 83:4-14. 2003
    ..These must involve collaboration with the private sector and communities, as well as strengthening of primary care services. Similarly, crucial is the rapid identification of solutions to TB/HIV and MDR-TB...
  2. ncbi The burden of drug-resistant tuberculosis and mechanisms for its control
    M C Raviglione
    Communicable Diseases, Stop TB, World Health Organization, Geneva, Switzerland
    Ann N Y Acad Sci 953:88-97. 2001
    ..The global epidemiology of drug-resistant TB, the impact of standardized short-course chemotherapy (SSC), and the potential future evolution of MDR TB are discussed in this chapter...
  3. ncbi WHO's new Stop TB Strategy
    Mario C Raviglione
    Stop TB Department of WHO, 20 Avenue Appia, CH-1211, Geneva 27, Switzerland
    Lancet 367:952-5. 2006
  4. ncbi Standard short-course chemotherapy for drug-resistant tuberculosis: treatment outcomes in 6 countries
    M A Espinal
    World Health Organization, Communicable Diseases Programme, Ave Appia 20, 1211 Geneva 27, Switzerland
    JAMA 283:2537-45. 2000
    ....
  5. ncbi Assessment of worldwide tuberculosis control. WHO Global Surveillance and Monitoring Project
    M C Raviglione
    Global Tuberculosis Programme, World Health Organization, Geneva, Switzerland
    Lancet 350:624-9. 1997
    ....
  6. ncbi Planning to improve global health: the next decade of tuberculosis control
    Dermot Maher
    Stop TB Department, WHO, Geneva, Switzerland
    Bull World Health Organ 85:341-7. 2007
    ..This approach to planning for global tuberculosis control is a valuable example of developing plans to improve global health that has relevance for other health issues...
  7. ncbi Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project
    C Dye
    Communicable Diseases Prevention and Control, World Health Organization, Geneva, Switzerland
    JAMA 282:677-86. 1999
    ..To estimate the risk and prevalence of Mycobacterium tuberculosis (MTB) infection and tuberculosis (TB) incidence, prevalence, and mortality, including disease attributable to human immunodeficiency virus (HIV), for 212 countries in 1997...
  8. ncbi Global trends in resistance to antituberculosis drugs. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance
    M A Espinal
    Communicable Diseases Cluster, World Health Organization, Geneva, Switzerland
    N Engl J Med 344:1294-303. 2001
    ..Data on global trends in resistance to antituberculosis drugs are lacking...
  9. ncbi Towards universal access to HIV prevention, treatment, care, and support: the role of tuberculosis/HIV collaboration
    Alasdair Reid
    Stop TB Department, WHO, Geneva, Switzerland
    Lancet Infect Dis 6:483-95. 2006
    ....
  10. ncbi DOTS expansion: will we reach the 2005 targets?
    L J Véron
    World Health Organization, Stop TB Department, Geneva, Switzerland
    Int J Tuberc Lung Dis 8:139-46. 2004
    ..The current efforts should be maintained and strengthened in order to approach these targets...
  11. ncbi XDR tuberculosis--implications for global public health
    Mario C Raviglione
    Stop TB Department, World Health Organization, Geneva
    N Engl J Med 356:656-9. 2007
  12. ncbi WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update
    D Falzon
    Stop TB Dept, World Health Organization, Geneva 27, Switzerland
    Eur Respir J 38:516-28. 2011
    ..Controlled trials are needed to improve the quality of existing evidence, particularly on the optimal composition and duration of MDR-TB treatment regimens...
  13. ncbi Determinants of drug-resistant tuberculosis: analysis of 11 countries
    M A Espinal
    World Health Organization, Communicable Diseases, Geneva, Switzerland
    Int J Tuberc Lung Dis 5:887-93. 2001
    ..Eleven countries/territories...
  14. ncbi HIV-associated tuberculosis in developing countries: clinical features, diagnosis, and treatment
    M C Raviglione
    Tuberculosis Unit, WHO, Geneva, Switzerland
    Bull World Health Organ 70:515-26. 1992
    ..Thioacetazone should be abandoned, because of severe adverse reactions observed among HIV-infected patients. The roles of preventive chemotherapy and BCG vaccination for prevention of tuberculosis are also briefly discussed...
  15. ncbi Evolution of tuberculosis control and prospects for reducing tuberculosis incidence, prevalence, and deaths globally
    Christopher Dye
    Stop TB Department, World Health Organization, Geneva, Switzerland
    JAMA 293:2767-75. 2005
    ....
  16. ncbi Tuberculosis control and elimination 2010-50: cure, care, and social development
    Knut Lonnroth
    Stop TB Department, WHO, Geneva, Switzerland
    Lancet 375:1814-29. 2010
    ....
  17. ncbi New drugs and new regimens for the treatment of tuberculosis: review of the drug development pipeline and implications for national programmes
    Christian Lienhardt
    Stop TB Department and Stop TB Partnership, World Health Organization, Geneva, Switzerland
    Curr Opin Pulm Med 16:186-93. 2010
    ....
  18. ncbi The "vertical-horizontal" debates: time for the pendulum to rest (in peace)?
    Mukund Uplekar
    Stop TB Department, World Health Organization, Geneva, Switzerland
    Bull World Health Organ 85:413-4. 2007
  19. ncbi Patients with previously treated tuberculosis no longer neglected
    Matteo Zignol
    Stop TB Department, World Health Organization, Geneva, CH 1211, Switzerland
    Clin Infect Dis 44:61-4. 2007
    ..Previously treated patients are difficult to re-treat and represent an important source of disease transmission, as well as a serious threat to TB control worldwide, because of their higher rate of drug resistance...
  20. ncbi Multidrug-resistant tuberculosis management in resource-limited settings
    Eva Nathanson
    Stop TB Department, World Health Organization, Geneva, Switzerland
    Emerg Infect Dis 12:1389-97. 2006
    ..In resource-limited settings, treatment of MDRTB provided through, or in collaboration with, national TB programs can yield results similar to those from wealthier settings...
  21. ncbi Erasing the world's slow stain: strategies to beat multidrug-resistant tuberculosis
    Christopher Dye
    Communicable Diseases, World Health Organization, CH 1211 Geneva 27, Switzerland
    Science 295:2042-6. 2002
    ....
  22. ncbi Increasing transparency in partnerships for health--introducing the Green Light Committee
    Rajesh Gupta
    World Health Organization, Geneva, Switzerland
    Trop Med Int Health 7:970-6. 2002
    ..The GLC mechanism may be useful in the development of other partnerships needed in the rational allocation of resources and tools for combating additional infectious diseases...
  23. ncbi Scaling-up treatment for HIV/AIDS: lessons learned from multidrug-resistant tuberculosis
    Rajesh Gupta
    Office of the Director General, WHO, Geneva, Switzerland
    Lancet 363:320-4. 2004
    ..The successes of the GLC and the obstacles it has encountered provide insights for building sustainable HIV/AIDS treatment programmes...
  24. ncbi Secular trends of tuberculosis in western Europe
    M C Raviglione
    Tuberculosis Programme, World Health Organization, Geneva, Switzerland
    Bull World Health Organ 71:297-306. 1993
    ..Tuberculosis remains a global disease and because of increasing human migrations, its elimination in Western Europe cannot be envisaged without concomitant improvements in its control in high-incidence, resource-poor countries...
  25. ncbi Rebuttal: Evidence and uncertainties
    Rajesh Gupta
    World Health Organization, Geneva, Switzerland
    Int J Tuberc Lung Dis 6:651-3. 2002
  26. ncbi Zoonotic tuberculosis due to Mycobacterium bovis in developing countries
    O Cosivi
    World Health Organization, Geneva, Switzerland
    Emerg Infect Dis 4:59-70. 1998
    ....
  27. ncbi Evolution of WHO policies for tuberculosis control, 1948-2001
    M C Raviglione
    Tuberculosis Strategy and Operations, StopTB, WHO, Geneva, Switzerland
    Lancet 359:775-80. 2002
    ..A multisectoral approach that builds on global and national partnerships is the key to future tuberculosis control...
  28. ncbi The growing burden of tuberculosis: global trends and interactions with the HIV epidemic
    Elizabeth L Corbett
    Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, England, UK
    Arch Intern Med 163:1009-21. 2003
    ..The prevention of HIV and TB, the extension of WHO DOTS programs, and a focused effort to control HIV-related TB in areas of high HIV prevalence are matters of great urgency...
  29. ncbi From threat to reality: the real face of multidrug-resistant tuberculosis
    Marcos Espinal
    Am J Respir Crit Care Med 178:216-7. 2008
  30. ncbi The new Stop TB Strategy and the Global Plan to Stop TB, 2006-2015
    Mario C Raviglione
    Bull World Health Organ 85:327. 2007
  31. ncbi Scale up: meeting targets in global tuberculosis control
    Gijs Elzinga
    RIVM (National Institute for Public Health and the Environment, Bilthoven, Netherlands
    Lancet 363:814-9. 2004
    ....
  32. ncbi Tuberculosis care and control
    Philip C Hopewell
    Bull World Health Organ 84:428. 2006
  33. ncbi The Global Plan to Stop TB, 2006-2015
    Mario C Raviglione
    Int J Tuberc Lung Dis 10:238-9. 2006
  34. ncbi The global tuberculosis situation. Progress and problems in the 20th century, prospects for the 21st century
    J Peter Cegielski
    Division of Tuberculosis Elimination, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    Infect Dis Clin North Am 16:1-58. 2002
    ..Still, recent developments in immunology, biochemistry, and molecular biology suggest that new knowledge and tools are just around the corner. These will enhance the ability to conquer this microbe by the end of the current century...
  35. ncbi Extensively drug-resistant tuberculosis, Italy and Germany
    Giovanni Battista Migliori
    Emerg Infect Dis 13:780-2. 2007
  36. ncbi International standards for tuberculosis care
    Philip C Hopewell
    Division of Pulmonary and Critical Care Medicine, San Francisco General Hospital, University of California, San Francisco, CA 94110, USA
    Lancet Infect Dis 6:710-25. 2006
    ....
  37. ncbi Facing extensively drug-resistant tuberculosis--a hope and a challenge
    Mario C Raviglione
    N Engl J Med 359:636-8. 2008
  38. ncbi Mario C Raviglione. Interview
    Mario C Raviglione
    Lancet 367:895. 2006